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Selective activation of oncogenic Ha-rasinduced
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Summary A Ha-rastransformant '7-4', derived from mouse NIH/3T3 fibroblasts, was used to study the relationship between overexpression
of activated Ha-ras and cell apoptosis. This cell line contains an inducible Ha-rasVa12 oncogene, which was under the regulation of the
Escherichia coli (E. coli) lac operator/repressor system. We demonstrate that overexpression of activated Ha-ras oncogene by exogenous
isopropyl-o-D-thiogalactoside (IPTG) under serum-depleted conditions can stimulate cell apoptosis. Cell cycle analysis showed that most of
the 7-4 cells with Ha-ras overexpression accumulated at S-phase and that the expression level of p34cdC2 kinase was decreased, suggesting
that p34cdc2 may be involved in 7-4 cell apoptosis. Overexpression of bcl-2 transgene in these cells blocked Ha-ras-induced apoptosis, and
this blockage was confirmed downstream of Ha-ras gene expression. Cycloheximide blocked the apoptosis of 7-4 cells in a dose-dependent
manner, indicating that specific protein regulating apoptosis may be synthesized through Ha-ras overexpression. Ha-ras overexpression-
triggered apoptosis was also prevented in the 7-4 derivatives that express either dominant-negative rasAsnl7 or dominant-negative raf-1C4B to
suppress Ha-ras signal transduction at different stages, indicating that overexpression of activated Ha-ras can induce cell apoptosis and that
raf-1 pathway activity is required for this process.
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Three ras proto-oncogenes (H-, K- and N-ras) in the ras family
are found in the mammalian genome (Downward, 1992). The acti-
vated ras oncogenes (such as the viral v-ras oncogenes) that are
derived from normal cellularproto-oncogenes and activated by the
mutations at amino acid position 12 and several other sites are the
most frequently identified oncogenes in human neoplasia, indi-
cating that ras oncogenes play an important role in the process of
carcinogenesis (Barbacid, 1987). Extensive studies have demon-
strated that cell proliferation and differentiation are dependent
upon Ras. This includes the raf-l product and the mitogen-acti-
vated protein (MAP) kinase. In recent studies, several investiga-
tors have suggested that the role of activated ras oncogenes in the
process ofcarcinogenesis is to provide cells with not only a selec-
tive proliferation function but also an antiapoptotic function (Sakai
et al, 1994). Arends et al (1994) reported that transfectants with
moderate or high oncogenic Ha-rasvall2 expression showed
reduced apoptosis. Several reports have also suggested that
expression of oncogenic ras has the ability to prevent apoptosis
and increase cell survival to anti-cancer drugs orionizing radiation
at doses that demonstrate apoptosis (Arends et al, 1993; Sakai
et al, 1994; Jimenez et al, 1995). Conversely, some reports have
recently demonstrated that Ha-ras oncogene overexpression could
induce apoptosis, which includes promoting the sensitivity of
murine fibroblast lOTl/2 cells to apoptosis induced by tumour
necrosis factor, inducing apoptosis ofJurkatcells after suppression
of protein kinase C (PKC) activity (Chen and Faller, 1996)
and triggering apoptosis of REF cells in the presence ofthe IRF-l
gene (Tanaka et al, 1994). Moreover, it is found that Ha-ras is an
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effective promoter of apoptosis through the Rafpathway, whereas
c-myc was found to be overexpressed under serum-deprived
conditions (Kauffmann-Zeh et al, 1997).
Furthermore, Fas ligation-induced apoptosis in immune homeo-
stasis needs normal ras activation (Gulbins et al, 1995). In the ras
superfamily, overexpression ofnormal rho-p21 or activated R-Ras
induces apoptosis in NIH/3T3 cells after serum deprivation
(Jimenez et al, 1995; Wang et al, 1995). Thus, either normal or
activated ras genes from the ras family or the ras superfamily may
be involved in apoptosis. The mechanisms of their action may
differ from one cell system to another. It is possible that the effects
depend on the status of other genes known to regulate apoptosis
(such as bcl-2, c-myc and p53) (Femandez et al, 1995).
In this report, a NIH/3T3 derivative designated 7-4 containing
an inducible Ha-rasvalI2 oncogene regulated by an Escherichia coli
lac repressor was used to demonstrate that Ha-ras overexpression
can indeed trigger apoptosis by manipulating the inducer of
isopropyl-p-D-thiogalactoside (IPTG). This apoptosis was further
confirmed by dominant-negative rasAsnl7 and raf-1C4B studies.
MATERIALS AND METHODS
Cell culture
Mouse fibroblast NIH/3T3 cells and their transgenic derivatives
(7-4, 7-4-2 and dominant-negative ras and raf-l cells) were main-
tained in a-modified Eagle medium (a-MEM; Gibco-BRL, USA)
containing 10% calf serum (Gibco) and incubated at 37°C in a
carbon dioxide incubator. The 7-4 cells contain plasmids
pSVlacOras andp3'SS (Stratagene, USA) (Liu et al, 1992; Ducoeur
et al, 1993); and 7-4-2 cells, a derivative of 7-4 cells, contain the
third plasmid pCAJ-bcl-2 (Tsujimoto, 1989). IPTG (Gold biotech-
nology, USA), a non-metabolizable lactose analogue, was added to
induce expression ofHa-ras transgene in 7-4 and 7-4-2 cells.
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Figure 1 Ha-ras oncogene was overexpressed in 7-4 and 212 cells by
IPTG induction under serum-deprived conditions. The cells were maintained
in 0.2% calf serum-containing medium in the absence or presence of 2.5 mM
IPTG for 48 h. Total RNA was then extracted and electrophoresed on a 1%
glyoxal gel. The probes used were an [a-32P]dCTP-labelled 4-kb BamHl
fragment of Ha-ras DNA from plasmid pSVlacOras and a 2-kb BamHl
fragment of f-actin DNA from plasmid pHFBA-1 (Liu et al, 1992). f-Actin is
used as an internal control
Table 1 Ha-ras gene overexpression caused accumulation of 7-4 cells at
S-phase under 0.2% serum condition
Cell cycle NIH/3T3 7-4 7-4 IPTG
GJG, 88% 48% 51%
S 9% 48% 90%
NIH/3T3 and 7-4 cells were cultured in 0.2% serum-containing medium for
24 h. IPTG (2.5 mM) was then added and the cells were harvested at 24-h
intervals. This table shows the result of 72 h post-IPTG treatment. A total of
5000 cells were analysed using flow cytometry.
DNA transfection
Cells (2 x 105) in a 60-mm plate were co-transfected with the
desired reporter plasmids (1.5-3 ,ug per plate) and pSGSlacZ P-
galactosidase reporter gene (0.5 ,ug per plate) as the internal
control using the Lipofectin method (Gibco-BRL) for 5 h. P-
Galactosidase activity was determined to calibrate the transfection
efficiencies. The cells were harvested and analysed 48 h after
transfection.
Microassay for cell viability
The microassay for cell viability was performed as described
previously (Ito, 1984). Briefly, cells were seeded in the 96-well
flat-bottom microplates (Nunc, Denmark) at appropriate concen-
trations (1-1.5 x 104 cells per 100gl per well) and incubated at
37°C in a carbon dioxide incubator for4 h for cell attachment. The
medium was then replaced with fresh medium. Eight wells were
used for each treatment. At the end ofthe incubation, the medium
was removed and the cells in wells were then fixed with 10%
formalin (50 ,l per well) for 10 min, after which they were stained
with 0.05% crystal violet (30gl per well) for 30 min. The stained
microplates were rinsed with tap water and then air dried. For the
determination of cell viability, colorimetry was used. The elution
fluid containing 50% ethanol and 0.1% acetic acid (150 p1 per
well) was added to each well, and the eluted blue dye in each well
was quantified by optical density measured at 590 nm(OD590) with
a Dynatech MR5000 microplate reader (Dynatech laboratories,
VA, USA). The percentage of inhibition was calculated according
to the following equation:
Per cent = 100 x
OD590(sample) - OD590(mediumcontrol)
inhibition OD590(cell control) -OD590(medium control)
Northern blot analysis
Thirty micrograms of total RNA prepared from the cells was
loaded into the wells on a 1% agarose gel containing 5 M glyoxal.
The RNA was fractionated by electrophoresis at 80 V, 80 mA, for
2 h, transferred to a Hybond-N transfer membrane in 25 mM
sodium phosphate, pH 6.5, and hybridized with the probes labelled
with [a-32P]dCTP to a specific activity of 4 x 108 dpm ig-' by
random priming (Sambrook et al, 1989). The blot was exposed to
Kodak X-OMAT AR film with the intensifying screen before
development (Liu et al, 1992).
Western blot analysis
Fifteen micrograms oftotal protein from the cells was denatured in
sodium dodecyl sulphate (SDS) lysis buffer (50 mm Tris-HCl,
pH 6.8, 2% SDS, 10% glycerol and 100 mM dithiothreitol) and
loaded into duplicated 12% SDS-polyacrylamide gels. After elec-
trophoresis at 100 V for 3 h in SDS-PAGE running buffer (25 mM
Tris-HCl, pH 8.8, 250 mM glycine, 0.1% SDS), one ofthe gels was
stained with 0.5% colorimetric Coomassie brilliant blue (Sigma,
USA) as a quantitative control and the other was transferred to the
polyvinylidine difluoride (PVDF) membrane (Stratagene) and
blocked with 5% skimmed milk in PBST (100 mm sodium
chloride, 80 mm disodium hydrogen phosphate, 20 mm sodium
dihydrogen phosphate, 0.2% Tween 20, pH 7.5) solution at 4°C
overnight. After washing with PBST and phosphate-buffered
saline (PBS) buffer, the membrane was hybridized with the mono-
clonal anti-Bcl-2 primary antibody (Dako, Japan) at 37°C for 1 h.
The membrane was then washed and hybridized with the mono-
clonal anti-mouse IgG conjugated with horseradish peroxidase
at 25°C for 1 h (KPL, USA). After washing, the membrane
was exposed to radiographic film (Fuji, Japan) for 10 min after
the enhanced chemiluminescence (ECL) detection reagents
(Amersham, USA) were added.
Flow cytometric analysis
The cells harvested in PBS solution were centrifuged at 130g for
5 min to remove the PBS; the cells were resuspended in 50 gl of
Hepes-buffered saline (HBS) solution [100 mM sodium chloride,
2.7 mm potassium chloride, 60 mm glucose, 10 mM Hepes, 0.1%
bovine serum albumin (BSA), pH 7.3]. Cells were stained with
5 ,l of merocyanine 540 (1 mg ml-'; Sigma) and incubated for
10 min at room temperature. Samples were then analysed using the
fluorescence-activated cell sorter (FACscan, Becton Dickinson,
USA). Each result from 5000 cells was analysed by the analysis
program CellFIT (McEvoy et al, 1988).
DNA fragmentation analysis
The harvested cells (1 x 106 per 100-mm plate) were washed with
PBS and pelleted by centrifugation at 240g twice. The cell pellets
were then treated with lysis buffer [1% NP-40 (Sigma) in 20 mM
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Figure 2 Effect of Ha-ras overexpression on morphological changes of NIH/3T3 and 7-4 cells. Subconfluent cells (1 x 105 per 100-mm plate) were cultured in
0.2% serum-containing medium for 24 h, and IPTG (2.5 mM) was then added in the same medium as the onset of the time course investigation. Cells were
photographed at 24, 48 and 72 h after IPTG addition (100x)
ETD, 50 mm Tris-HCl, pH 7.5] for 10 s and centrifuged for 5 min
at 3100 g twice. The supernatant was brought to 1% SDS with
RNAase A (5 ,ug pl-) and kept at 56°C for 2 h followed by diges-
tion with 2.5 gg ul-' proteinase K (Boehringer Mannheim) for at
least 2 h at 37°C. After addition of 0.5 vol 10 M ammonium
acetate, the DNA was precipitated with 2.5 vols 100% ethanol,
resuspended in TE buffer (10 mm Tris-HCl, pH 7.5, 1 mM EDTA)
and separated by electrophoresis on a 1% TAE-agarose gel at 30 V
for 8 h. The DNA fragments were visualized by ethidium bromide
staining (Hermann et al, 1994).
CAT assay
A 50-,ug cell lysate was incubated at 65°C for 10 min to denature
the deacetylase activities. Twenty microlitres (3.5 mg ml-') of
acetyl coenzyme A (Sigma) and 2 gl (sp. act. = 56 mCi mmol-1) of
['4C]chloramphenicol (Amersham, UK) were added to the lysate
and incubated at 37°C for 1 h. To stop the reaction, 1 ml of ethyl
acetate (BDH, UK) was added to each sample and 0.9 ml of the
upper phase was transferred to the new Eppendorf tube and dried
by a speed vac (Eyela, Japan). The pellet was resuspended in 10 tl
of ethyl acetate and dotted on the 25-mm thin-layer chromatog-
raphy silica plate (Merck, Germany). The samples were spread
by the chloroform-methanol mixture (95:5) (BDH, UK). The
percentage of ['4C]chloramphenol acetylated was quantified by
cutting the acetylated and non-acetylated spots and measuring the
amount of radioactivity using the scintillation counter (LS 5000
TA, Beckman, USA).
Luciferase and P-galactosidase activities assay
The luciferase andP-galactosidase activities were determined by a
Dual-Light luciferase and ,B-galactosidase reporter gene assay
system (Tropix, USA). Briefly, equivalent amounts of protein
lysates (the final volume was 10pl) were mixed with buffer A,
containing the reagents necessary for the luciferase reaction. Light
signal from the luciferase enzyme present in the extract was
measured immediately by a luminometer (Lumat, LB 9501,
Germany) after the addition of buffer B containing luciferin and
Galacton-plus. After another 30-min incubation, the light signal
from the accumulated product of ,B-galactosidase and Galacton-
plus reaction is initiated by the addition of a light emission accel-
erator and measured using the luminometer.
RESULTS
Ha-rastransgene was overexpressed in the
transformants in the presence of IPTG under
serum-deprived conditions
The Ha-rasval'2 oncogene (GGC to GUC) cloned from the human
T24 bladder carcinoma cell line (driven by an SV40 promoter with
the E. coli lac repressor-binding operator) was introduced into
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Figure 3 DNA fragmentation was detected in 7-4 cells while Ha-ras
transgene was overexpressed by IPTG induction. The cells (1.5 x 106 per
150-mm plate) were maintained in the medium containing 0.2% calf serum
for 24 h, 2.5 mm IPTG was then added to the same medium. Cells were
harvested and DNA was extracted at 24, 48 and 72 h. (A) Without IPTG;
(B) with IPTG; M, 1-kb DNA ladder marker
NIH/3T3 cells. Two cell lines, designated 212 and 7-4, have been
established. The activated Ha-ras oncogene in these two cell lines
can be overexpressed by IPTG induction under normal conditions
(Liu et al, 1992). To ensure that the Ha-ras oncogene could also be
overexpressed in thecells by IPTG induction under serum-deprived
+ IPTG
7-4 cells
Figure 4 Apoptotic 7-4 cells were evidently stained by acridine orange. The
cells (1 x 103 per slide) were maintained in the medium with 0.2% calf serum
for 24 h, IPTG was then added to overexpress Ha-ras oncogene. The cells
were fixed with 100% methanol and labelled with 1% acridine orange
48 h after IPTG induction (200x). (A) 7-4 cells without IPTG; (B) 7-4 cells
with IPTG
conditions, the assessment of basal and induced expression of the
Ha-ras transgene in these cells was performed by Northern blot
analysis. Very faint to undetectable Ha-ras signals in uninduced
responsive cells (Figure 1, lanes 1, 3 and 5) and intense bands in
induced cells (Figure 1, lanes 2 and 4) were detected 48 h after
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Figure 5 bc-2 transgene overexpression in 7-4-2 cells blocked apoptosis and altered the morphology. The cells (1.5 x 106 per 150-mm plate) were maintained
in medium containing 0.2% serum for 24 h, IPTG was then added as the onset of the time course investigation in the same medium. (A) Without IPTG; (B) with
IPTG; M, 100-bp DNA ladder marker; (C) for morphological observation, subconfluent cells (1 x 105 per 100-mm plate) were cultured in 0.2% serum containing
medium for 2 days in the presence of IPTG, and then were photographed (1OOx)
IPTG induction. The increase in band intensity in 212 and 7-4 cells
is 25 x and 15 x, respectively, compared with their basal expres-
sion. Western blot analysis shows identical results (data not
shown). The levels of Ha-ras overexpression and transforming
characteristics of212 and 7-4 cells are similar. Therefore, only 7-4
cells were used for the following analysis.
7-4 cells died of apoptosis while the Ha-ras oncogene
was overexpressed by IPTG induction under serum-
deprived conditions
The effects ofHa-ras overexpression on the cellcycle, morpholog-
ical changes, viability and apoptosis of7-4 cells were investigated.
For cell cycle analysis, the cells were initially synchronized by
0.2% serum starvation for 24 h and then treated with IPTG and
analysed at 24-h intervals for 3 days in the 0.2% serum-containing
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Figure 6 Cycloheximide blocked the apoptosis of 7-4 cells in a dose-
dependent manner. The cells (1.5 x 106 per 150-mm plate) were starved for
24 h in 0.2% serum containing medium, and IPTG was added for 6 h.
Cycloheximide was then added and incubated for another 72 h at the
concentrations as indicated. The cellular DNA was isolated, and DNA
fragmentation was analysed on a 1% agarose gel. Lane 6, 100-bp DNA
marker
medium. The percentage of 7-4 cells in G/G, phase was 48% in
the absence of IPTG and dropped to 5% in the presence of IPTG.
Correspondingly, the percentage of 7-4 cells in S-phase was 48%
in the absence ofIPTG and raised to 90% in the presence ofIPTG
at 72 h, indicating that the major 7-4 cell population accumulated
in S-phase while the Ha-ras gene was overexpressed. In contrast,
the percentage of cells in G2IM phase is constant at all the times
tested (Table 1).
Morphological observation shows that NIH/3T3 and 7-4 cells
exhibited similarflat andpolygonal morphology at 24 h after treat-
ment. The morphology ofNIH/3T3 cells remained the same at all
the times investigated. The morphology of uninduced 7-4 cells
became more spindle-like and formed slender processes at 48 and
72 h after induction. However, IPTG-induced 7-4 cells started
aggregating and showed contracted, rounded morphology in 48 h.
These cells formed small foci (containing 15-30 cells) and some
ofthem started floating and died between 48 and 72 h (Figure 2).
To clarify whether the death ofmajor 7-4 cells is apoptotic, the
cells maintained in 0.2% serum-containing medium with or
without IPTIG induction for48 and 72 h were analysed using DNA
fragmentation analysis and acridine orange staining. Evident DNA
fragmentation was detected in 7-4 cells maintained in 0.2% serum-
containing medium for 48 and 72 h, while Ha-ras was over-
expressed by IPTG induction (Figure 3B). IPTG per se or serum
deprivation alone without Ha-ras overexpression could not stimu-
late apoptosis of all the cells tested (Figure 3A). Moreover, many
7-4 cells were rounded, and in about 80% of the cells (797 ± 5 /
lx103 cells) the chromatin was condensed and heavily stained by
Figure 7 Western blotting demonstrates that the decreased levels of p34cdC2
in 7-4 cells was related to serum starvation and Ha-ras overexpression. The
cells (1 x 106 per 100-mm plate) were starved in 2% serum containing
medium for 24 h, IPTG was then added. Total protein lysates were extracted
at the time as indicated. An aliquot (50gg) of the total protein was
fractionated on the 12% SDS-polyacrylamide gel, and blotted onto the PVDF
membrane. The expression of p34c&2, Cyclin B and Ras were detected by
anti-p34cdc2, anti-Cyclin B and anti-Ras antibodies followed by enhanced
chemiluminescence detection using anti-mouse IgG
acridine orange in the presence of IPTG for 72 h. However, 7-4
cells without IPTG induction showed normal flat morphology with
very faint acridine orange staining. Less than 20% of the cells
were apoptotic (178 ±6 / 1 x 103 cells) (Figure 4).
Apoptosis of 7-4 cells triggered by Ha-ras
overexpression could be prevented by bcl-2
overexpression or cycloheximide treatment
To test whether bcl-2 transgene overexpression could block Ha-
ras oncogene-induced apoptosis, the 7-4-2 cells that stably
expressed the human bcl-2 gene (driven by an SV40 early
promoter) were investigated. The expression ofbcl-2 transgene at
transcriptional and translational levels in 7-4-2 cells was
confirmed (data not shown). DNA fragmentation in 7-4-2 cells
could not be detected, suggesting that bcl-2 overexpression could
block Ha-ras-induced apoptosis (Figure 5B, lanes 4-6). Neither
IPTG nor serum starvation was sufficient to induce cell apoptosis
without Ha-ras overexpression (Figure 5A). Moreover, 7-4-2 cells
also showed spindle-like morphology. In contrast, 7-4 cells with
significant DNA fragmentation started to contract and become
round at 48 h and aggregated together within 72 h (Figure 5C).
While protein synthesis inhibitor cycloheximide (CX) was
applied to 7-4 cells, Ha-ras-induced apoptosis was delayed in a
CX dose-dependent manner, indicating that de novo protein
synthesis is required for 7-4 cell apoptosis (Figure 6). Moreover,
CX per se without IPITG induction could not trigger 7-4 cell
apoptosis (Figure 6, lane 1).
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Figure 8 Dominant negative rasstably expressed in the derivatives of 7-4
cells blocked Ha-ras-induced AP-1 activity, and lowered the efficiency of
colony formation as well as cell growth rate. (A) For AP-1 activity analysis,
the 7-4 and Ras 1-3 cell lines (1 x 106 per 100-mm plate) were transiently co-
transfected with plasmid p5x colITRE-CAT (3 ,ug) and pSG51acZ (0.5 ig).
Plasmid p5x colITRE-CAT contains five tandem repeats of human
collagenase promoter TRE that can be activated by binding to AP-1 (Wang et
al, 1994). pSG51acZ was used as an internal control for transfection
efficiency. All the cells were maintained in the medium with 10% calf serum
plus 2.5 mm IPTG for 48 h, then the cells were harvested and analysed. CAT
activity was presented as the following:
Relative CAT activity = counts in acetylated species
(% of conversion) (counts in acetylated species
+ in non-acetylated species)
(B) For colony formation analysis, the cells (5 x 103 per 35-mm plate) were
plated into six-well trays and cultured in 0.33% agar containing the medium
supplemented with 10% calf serum in the presence of IPTG. Colonies were
counted at day 10. (C) For cell growth analysis, cells (1 x 103 per 96 wells)
were plated into 96-well trays in the medium with IPTG. The cell number was
counted at a 24-h interval for 5 days by the microassay (Ito, 1984)
The expression level of kinase p34cdc was decreased
while 7-4 cells were grown in serum-deprived
conditions accompanied by Ha-ras overexpression
To understand the possible factors involved in the aberration ofthe
7-4 cell cycle and subsequent cell apoptosis, the kinases cyclin A,
B andp34d2regulating the cell cycle fromG!GI to M-phase were
observed at the translational level.
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Figure 9 DNA fragmentation and apoptotic population were suppressed in
7-4 derivatives expressing dominant negative ras. (A) The cells (1.5 x 106
per 150-mm plate) were maintained in 0.2% serum containing medium for
24 h, then IPTG was added. Cellular DNA was extracted 48 h after treatment,
and analysed on a 1% agarose gel. Lane 1, 100-bp DNA marker; lane 2, 7-4
cells with DNAfragmentation as a positive control; lanes 3-5 are Ras 1-3 cell
lines expressing dominant negative ras. (B) The cells (2 x 105 per 35-mm
plate) were treated the same as in A. The cells were labelled with
merocyanine 540 (50 gg ml-'; Sigma, USA) for 10 min in the dark, then
analysed using the FACScan (Becton Dickinson, USA). Merocyanine 540,
like Annexin V, can bind to the membrane phospholipid phosphatidylserine,
which was translocated from innerface of the membrane to the surface of
early apoptotic cells, and is used as the indicator of apoptosis. y-axis is the
cell number; x-axis is the fluorescence intensity; bar indicates the percentage
of apoptotic population
The treatment of the cells is the same as described above.
Briefly, cell lysates were extracted at a 24-h interval until 72 h
afterIPTG induction, andthe expression levels ofp34cdc2, cyclin A
and B were investigated. Figure 7A shows the expression levels of
p34cdc2 and cyclin B using western blotting. Evidently, the p34cdc2
protein levels were inversely decreased, whereas the time for
IPTG treatment was increased under 0.2% serum-containing
medium. Comparatively, the expression levels of cyclin B were
unchanged. Similar to cyclin B, the expression level of cyclin A
was unchanged as well (data not shown). The falling of p34cdc2
expression either due to Ha-ras overexpression or due to serum
deprivation or due to both was determined by administration of
IPTG. Figure 7B demonstrates that serum deprivation alone could
cause significant falling of p34cdc2 (Figure 7B, lanes 1, 2 and 4),
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Figure 10 Dominant negative raf-1 expressed in the derivatives of 7-4 cells
blocked Ha-ras overexpression induced Elk activity, and lowered the
efficiency of colony formation and growth rate. (A) For Elk activity analysis,
7-4 and Raf E, F and M cells (1 x 106 per 100-mm plate) were co-transfected
with pFAElk (1.5gg), pFRLuc (1.5 jg) and pSG51acZ (0.5 igg), which was
used as an internal control for transfectin efficiency. All the cells were
maintained in the medium with IPTG for 48 h, then harvested and analysed
for luciferase and 1-galactosidase activities (see Materials and methods).
(B) The procedures for colony formation and cell growth analysis are the
same as described in Figure 8 B and C
and Ha-ras overexpression (1.95- to 2.8-fold) further enhanced
this suppression by 1.8- to 2-fold (Figure 7B, lanes 2 and 3, 4 and
5). Moreover, the phosphorylation of p34cdc2 was not affected by
Ha-ras overexpression under serum-deprived conditions (unpub-
lished data). The decrease in p34cdc2 at the translational level seems
to play an important role in disruption ofthe cell cycle.
Dominant-negative ras and dominant negative raf-1
blocked Ha-ras overexpression-induced apoptosis at
different signal transduction stages
To ensure that Ha-ras indeed triggers the apoptosis of7-4 cells, the
dominant negative ras [in plasmid pZIPneoAsn17 with a mutation
at amino acid 17 (serine to asparagin)] was transfected into 7-4
cells to block Ras activity (Feig and Cooper, 1988). Three stable
11
Fluorescence
Figure 11 DNA fragmentation and apoptotic population were suppressed in
7-4 derivatives expressing dominant negative raf-1. Cell maintenance and
treatment were the same as described in Figure 9. (A) DNA fragmentation
analysis. (B) Quantification of apoptotic cells
transfectants Ras 1, Ras 2 and Ras 3 with higher levels of domi-
nant negative ras expression show lower AP-1 activity (Figure
8A), lower efficiency of colony formation (Figure 8B) and slower
cell growth rate (Figure 8C) compared with the parental 7-4 cells,
indicating that dominant-negative ras effectively blocked Ras
activity. AP- consists ofthe members ofthejun and the fos fami-
lies, which can be activated by RAS; therefore, its activity can be
used as the indicator ofRas activity. Moreover, the degree ofDNA
fragmentation and the population of apoptotic cells were all
evidently decreased in these dominant-negative ras cell lines
(Figure 9A and B), indicating that ras indeed plays a major role in
7-4 cell apoptosis.
Raf-1 is an effector of activated Ras and its downstream trans-
ducers are MAPK, Erk and Elk (Kauffmann-Zeh et al, 1997). To
unveil whether ras-triggered apoptosis is through the raf-l
signalling pathway, the dominant negative raf-i gene (in plasmid
pRafC4B, with a deletion at 3' end kinase domain) was transfected
into 7-4 cells (Bruder et al, 1992). Three cell lines RafE, RafF and
Raf M stably expressing the raf-l gene were established (data not
shown). To determine the activity ofRaf-1, its downstream substrate
Elk activity was measured by the PathDetect Elk-trans-reporter
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system (Stratagene). This reporting system contains a pFAElk fusion
activator plasmid and a pFRLuc reporter plasmid. The fusion acti-
vator plasmid expresses the pathway-specific transactivator protein
that consists ofthe DNA-binding domain ofthe yeast GAML and the
activation domain ofthe Elk transcription factor. Because this fusion
activator pFAElk is phosphorylated and activated by Raf-1, its
activity reflects the in vivo activation of this kinase and the corre-
sponding signal transduction pathway. The Raf-l activity, efficiency
ofcolony formation and the rate of cell growth of Raf F and Raf M
were decreased to various degrees compared with their parental 7-4
cells, indicating that Rafactivity was blocked by the dominant nega-
tive raf-I (Figure IOA and C). Comparatively, Raf E showed much
less efficiency in suppression of Raf activity, colony formation and
cell growth. We found the mRNA level in Raf E cells is the lowest
compared with the other two cells lines (data not shown).
Correspondingly, the degree of DNA fragmentation and population
of apoptotic cells in Raf F and Raf M were much lower than that in
Raf E and 7-4 cells, indicating that the raf-l signalling pathway is
indeed required for 7-4 cell apoptosis (Figure llA and B).
DISCUSSION
It is conceivable that activated Ha-ras may alter the interactions
between regulatory accessory factors such as Ras-GAP and Ras-
GEF, thereby leading to deregulation of one or more members of
the GTP-binding ras superfamily (Bokoch and Der, 1993), such as
ran/TC4 (Basu et al, 1992). The product of ran/TC4 is necessary
for the function of RCC1, which is a gene product involved in co-
ordinating the end of the S-phase and chromosome condensation
(Ren et al, 1993). It is also known that inappropriate expression of
normal or activated ras can interfere with normal cell cycle
progression (Feramisco et al, 1984; Mulcahy et al, 1985). Denko et
al (1994) have shown that selective induction of the activated Ha-
ras transgene with IPTG is sufflcient to disrupt at least one cell
cycle control point by stimulating serum-deprived 212 cells to
progress fromGU arrest into S-phase. All the data indicate that acti-
vated ras can facilitate the transition fromGI to S-phase ofthe cell
cycle. This phenomenon is consistent with our observation of 7-4
cells that accumulated in S-phase while activated Ha-ras was over-
expressed by IPTG.
The disruption ofthe normal cell cycle that resulted in the death
of the cells has been reported (Rubin et al, 1993). Meikrantz et al
(1994) classified the death of S-phase-arrested cells in an asyn-
chronous population into multiple forms ofapoptosis. The correla-
tion between S-phase arresting and apoptosis may explain that 7-4
cells with a major population of S-phase-arrested cells showed
high mortality, significant DNA fragmentation and strong acridine
orange staining. Such cell cycle disruption may result from either
gene expression at the wrong time or aberrant expression of
normal cell cycle kinases, including activation or inactivation
(Rubin et al, 1993). Chen and Pan (1994) reported that in Xenopus
oocytes, Ha-ras oncogene overexpression suppressed the activity
but not the expression level of p34cdc2, and subsequently led the
cell to rest in M-phase. In our study, Ha-ras overexpression greatly
suppressed p34cdc2 expression level and led the cells to accumulate
in S-phase.
Many factors may be involved in the process ofHa-ras-induced
apoptosis, but the relationships largely remain unknown (Whyte
and Evan, 1995). The possible mechanisms of Ha-ras overexpres-
sion-induced apoptosis in 7-4 cells are as follows: (a) overexpres-
sion of Ha-ras oncogene inactivates cell cycle-related kinases
(such as the kinase p34cdc2) (Girard et al, 1991); (b) Ha-ras overex-
pression shuts off the expression of 'survival' genes, such as bcl-2
in the absence of appropriate growth factors under serum depleted
condition and guides cells to death; (c) the unknown factor that
triggered the apoptotic pathway was specially activated in 7-4 cells
(such as IRF- 1) (Tanaka et al, 1994).
Overexpression of the bcl-2 gene blocked Ha-ras-induced apo-
ptosis but had no effect on Ha-ras oncogene expression, indicating
that its prevention of apoptosis is downstream in the Ha-ras
signalling pathway (unpublished data). Moreover, Bcl-2 and p2lras
molecules can be co-immunoprecipitated in Jurkat cells, and phos-
phorylation of the Bcl-2 protein is involved in the prevention of
cell apoptosis (Chen and Faller, 1996). However, the precise
mechanism by which the bcl-2 gene prevents Ha-ras-induced
apoptosis remains to be determined.
Our results from (a) selective overexpression of activated Ha-
ras oncogene by IPTG; and (b) specific blockage of Ras activity
by dominant negative ras or dominant negative rafclearly demon-
strate that overexpression of activated Ha-ras indeed induces 7-4
cells apoptosis under serum-deprived conditions. Activated Ha-
ras-induced apoptosis was also detected in the other transformant
212 cells. But the degree of apoptosis was less severe compared
with 7-4 cells, indicating that factors other than Ha-ras activation
may also be involved. However, our observation that 7-4 cells
proceeded with apoptosis without c-myc overexpression (unpub-
lished data) is different from Kauffmann-Zeh's report that both
Ha-ras and c-myc are overexpressed in the apoptosis of the fibro-
blasts (Kauffmann-Zeh et al, 1997). This contrasting result indi-
cates that c-myc overexpression is not an inducing factor but an
end-point response of Ha-ras-induced apoptosis.
The effect ofserum starvation on long-term viability ofthe cells
was observed by measuring the percentage of dye excluding cells
that were stained with 0.04% trypan blue at a 24-h interval. We
found that, 72 h after starvation, the percentage of viable 7-4 cells
is 88% in the absence ofIPTG and drops to 50% in the presence of
IPTG compared with NIH/3T3 cells (100%), indicating that
NIH/3T3 and 7-4 cells could stand long-term starvation (unpub-
lished data). Ha-ras gene overexpression makes 7-4 cells more
vulnerable to serum deprivation and induces them to apoptosis.
The uncertainty whether nutrient deficiency caused by serum
starvation may induce cell apoptosis was clarified by growing the
cells in the medium supplemented with 10% AC-2 (Valio, Finland;
collostrum, a serum substitute). We found that NIH/3T3 and a lung
carcinoma cell line H2981 could grow normally in this kind of
medium (unpublished data). In contrast, 7-4 cells with Ha-ras
overexpression maintained in the same conditions underwent
apoptosis, indicating that serum depletion causing nutrient defi-
ciency is not a determining factor ofapoptosis. It is consistent with
Kulkarni's report that serum starvation only caused minor cell
apoptosis (Kulkarni and McCulloch, 1994). The amount ofcertain
growth factors such as IGF-I in either 0.2% serum or 10% AC-2
may be critical to determine cell survival ordeath. A detailed study
is under way.
Dominant negative raf-l blocked the Raf-1-MAPK pathway and
prevented apoptosis of 7-4 cells, indicating that Ha-ras-induced
apoptosis needs Raf-I-MAPK pathway activity, which is consistent
with Kauffmann-Zeh's observation that Raf-l-MAPK is an apo-
ptotic pathway. It seems that the Raf-MAPK pathway is a common
pathway forboth proliferation and apoptosis. We hypothesize that in
NIH/3T3 fibroblasts while Ha-ras was overexpressed, serum starva-
tion as an exogenous stress will turn on the apoptotic signal through
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Ha-ras and raf-1 signalling pathways. The fate ofthe cells will then
be executed by downstream specific nuclear transactivators, which
are formed after Ha-ras activation and activated through dimer
formation (such as the pairing of the members ofjun andfor fami-
lies) that activate either survival genes or apoptotic genes. Ha-ras
overexpression activated downstream from the expression of apo-
ptotic-related genes was sustained by a protein synthesis inhibitor
cycloheximide study, which delayed 7-4 cell apoptosis.
In conclusion, our study demonstrates that Ha-ras,,12 over-
expression without c-myc overexpression can trigger cell apoptosis
This apoptosis may use the Raf-l-MAPK pathway to synthesize
specific nuclear factors and subsequently to turn on apoptotic-related
genes. These events were confirmed by the studies of dominant-
negative ras, raf-1, cycloheximide and bcl-2 gene overexpression.
The relationship between Ha-rasvaIl2 oncogene overexpression
and cell apoptosis observed in our laboratory will shed light on the
understanding of Ha-ras oncogene-related apoptosis and aid in
unveiling the factors that lead tumour cells with the expression of
activated Ha-ras oncogene to programmed cell death.
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